Listed by the USPTO as MORGAN, BAILEY MICHELLE
Tech Center 1600 • Art Units: 1644 1645
This examiner grants 56% of resolved cases
MORGAN, BAILEY MICHELLE examines in tech center 1600 and art unit 1644. The profile records 32 resolved cases, an allowance rate of 56.3%, and interview lift of 58.3%. The median time to allowance is 1223 days. Interviews are associated with a substantial change in allowance outcomes in this record, while the overall allowance rate indicates that both allowed and non-allowed matters are represented.
The listed companies are Washington University, Sichuan University, and CJ CheilJedang Corporation. The listed firms are JCIP, Abel Schillinger, LLP, and BIRCH STEWART KOLASCH & BIRCH, LLP. Counsel may wish to give interviews a deliberate role in prosecution planning, while allowing for the 1223-day median when advising on timing. The 32-case sample provides useful context but remains matter-specific.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18847051 | MICROORGANISM WITH ENHANCED ACTIVITY OF ASPARTATE 1-DECARBOXYLASE DERIVED FROM TRIBOLIUM CASTANEUM, AND USES THEREOF | Non-Final OA | CJ CheilJedang Corporation |
| 17796565 | VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18732214 | ANTI-ROXP ANTIBODIES AND USES THEREOF | Non-Final OA | Washington University |
| 18666803 | RHODOPSEUDOMONAS PALUSTRIS TIE-1 STRAINS AND METHODS FOR BIOPLASTIC PRODUCTION | Non-Final OA | WASHINGTON UNIVERSITY |
| 18034102 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR ALPHA-HYDROMUCONIC ACID, AND METHOD FOR PRODUCING CHEMICAL PRODUCT | Non-Final OA | TORAY INDUSTRIES, INC. |
| 17769899 | COMPOSITIONS AND METHODS FOR PRODUCING ENHANCED IMMUNE RESPONSES AND RAPID ANTIBODY PRODUCTION | Final Rejection | University of Virginia Patent Foundation |
| 18487614 | FLUORESCENCE RESONANCE ENERGY TRANSFER-BASED BIOSENSOR FOR SENSING CHIMERIC ANTIGEN RECEPTOR ACTIVITY AND USE THEREOF | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&db FOUNDATION |
| 18042231 | COMBINATION IMMUNOTHERAPY METHODS FOR THE TREATMENT OF CANCER | Final Rejection | The Board of Regents of The University of Texas System |
| 18257420 | CONJUGATED T-2 TOXIN TO PROTECT AGAINST MYCOTOXICOSIS | Final Rejection | INTERVET INC. |
| 17794744 | INCREASED ETHANOL PRODUCTION BY OVEREXPRESSION OF JID1 IN YEAST | Final Rejection | DANISCO US INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy56.3% of resolved applications examined by Bailey Michelle Morgan were allowed (32 resolved cases), compared with 35.8% across Art Unit 1644 over the last five years.
This examiner's interview lift is +58.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Bailey Michelle Morgan took 1,223 days on average from filing to allowance.
Bailey Michelle Morgan examines applications in Art Unit 1644 in Tech Center 1600 (Biotechnology & Pharmaceuticals).